Кабазитаксел во второй линии химиотерапии рака предстательной железы — клинико-экономическая оценка
Качественная клиническая практика, 2018 Актуальность. Сегодня в России наблюдается более 50 тыс. мужчин с распространённым и/или метастатическим раком предстательной железы (РПЖ), лечение которых требует определённых медицинских ресурсов и экономических затрат.
doaj
[Alemtuzumab-induced Graves' disease]. [PDF]
Probl Endokrinol (Mosk), 2023 Sheremeta MS +6 more
europepmc +1 more source
[Definitive treatment of Graves' disease in children]. [PDF]
Probl Endokrinol (Mosk), 2022 Ivannikova TE +5 more
europepmc +1 more source
[Spontaneous remission of neuroendocrine diseases due to apoplexy in hormonally active pituitary adenomas]. [PDF]
Probl Endokrinol (Mosk)Vishnyakova VO +3 more
europepmc +1 more source
[Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases]. [PDF]
Probl Endokrinol (Mosk), 2023 Gronskaia SA +23 more
europepmc +1 more source
[The clinical case of IgG4-related thyroid disease in a 6-year-old child]. [PDF]
Probl Endokrinol (Mosk), 2023 Kolodkina AA +6 more
europepmc +1 more source
[The role of an interdisciplinary approach to the treatment of patients with reduced ovarian reserve, premature ovarian insufficiency and mood disorders]. [PDF]
Probl Endokrinol (Mosk)Absatarova YS +5 more
europepmc +1 more source
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease]. [PDF]
Probl Endokrinol (Mosk), 2023 Perepelova MA +5 more
europepmc +1 more source
[The History of the Development of Radioiodine Therapy in Russia]. [PDF]
Probl Endokrinol (Mosk)Sheremeta MS +3 more
europepmc +1 more source